Scientific Publications

Home > Scientific Publications
Date Title
Oct 2017 Placenta-Derived Adherent Stromal Cells Improve
Feb 2016 Human placenta-derived stromal cells decrease inflammation, placental injury and blood pressure in hypertensive pregnant mice
Oct 2015 In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications
Sep 2015 Mesenchymal Stromal Cells Prevent Allostimulation in vivo and Control CheckPoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation
Aug 2015 Concise Review: Process Development Considerations for Cell Therapy
Aug 2015 Critical elements in the development of cell therapy potency assays for ischemic conditions
Dec 2014 Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal 2 cells confer neuroprotection to nerve growth factor (NGF)-differentiated 3 PC12 cells exposed to ischemia by secretion of IL-6 and VEGF
Mar 2014 Could Placental Cell Therapy be a Preemptive Approach to Protecting Women from Disabling Strokes?
Mar 2014 CELL THERAPIES – The Challenges & Possible Solutions for Transferring Cell Therapy From the Bench to the Industry
Nov 2013 Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model
Oct 2013 Self Healing- Article from European Biopharmaceutical Review
Oct 2013 Cell Therapy: Pushing Cells Around
Oct 2013 Commentary: A guide for potency assay development of cell-based product candidates
Jun 2013 Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells
Oct 2011 Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS)
Feb 2010 Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats
Feb 2010 Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table
Jun 2009 The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia
May 2009 Safety and Biodistribution Profile of Placental-derived Mesenchymal Stromal Cells (PLX-PAD) Following Intramuscular Delivery
Apr 2009 Cytokines as the Major Mechanism of MSC Clinical Activity: Expanding the Spectrum of Cell Therapy
Aug 2008 Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood